Expert Ratings for Surgery Partners
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Surgery Partners (NASDAQ:SGRY) stock. The analysts have an average price target of $48.8, implying an upside from the current price of $32.35. This current average represents a 6.15% decrease from the previous average price target of $52.00.
September 14, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts predict an upside for Surgery Partners with an average price target of $48.8, a decrease from the previous target.
The analysts' average price target for Surgery Partners indicates a potential upside from the current price, which is generally a positive signal for the stock. However, the decrease from the previous target might suggest a slightly less optimistic view on the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100